Dezima Pharma
Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Dezima Pharma Information
Dezima Pharma was acquired by
Amgen.
The acquisition happend on 2015-09-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Gooimeer 2-35
City: Naarden
State: noord-holland
Zip: 1411
Country: NL
Financial Info
Stage:
series unknown
Raised Last:
$19M
Raised Total:$13M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Dezima Pharma is engaged in the development of novel drugs to treat cardiovascular disease related to dyslipidemia.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2013 | Series A | $12.8M |
Forbion Capital Partners BioGeneration Ventures B.V. |
2/2013 | Venture Round | 3 | $18.6M |
BioGeneration Ventures Forbion Capital Partners New Science Ventures BioGeneration Ventures Forbion Capital Partners New Science Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
